33,000
Participants
Start Date
October 28, 2019
Primary Completion Date
November 3, 2022
Study Completion Date
December 31, 2023
Offering an alternative cervical cancer screening method - hrHPV molecular testing.
"Women randomized to this screening strategy group will take a hrHPV molecular test.~hrHPV-positive - reflex LBC:~Abnormal reflex LBC (ASC-US or worse) -\> colposcopy~Normal reflex LBC -\> repeat LBC in 6 months~Positive - colposcopy~Negative - rescreen in 3 years~HPV-negative - rescreen in 5 years"
Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw
Ministry of Health, Poland
OTHER_GOV
Maria Sklodowska-Curie National Research Institute of Oncology
OTHER